AzTrials
AzTrials

Adolescent Idiopathic ScoliosisMEDULLOSCOLNCT04760808

Evaluation of Cerebrospinal Fluid Flow in Adolescent Idiopathic Scoliosis

An observational study of Adolescent Idiopathic Scoliosis, run by Lille Catholic University at 2 sites in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Adolescent Idiopathic Scoliosis (AIS) is the most frequent spinal deformity in adolescence, but its etiology remains unknown. Recent publications suggest a link between ciliopathy and AIS. Read more about this study

Who is it for?
Ages 12 to 17 years, women onlyHealthy volunteers can take part
Conditions the study is for
Adolescent Idiopathic Scoliosis
What is being tested?
Baseline Clinical Examination, Initial 3T MRI of the Brain and Spine and 6-month Follow-up Clinical Examination
Type of treatment
Surgery or procedure
How many people
72 participants
Where
2 sitesFrance
Study dates
10 Feb 2021to 4 May 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 to 17 years
  • Women only
  • Healthy volunteers accepted
  • Child

Study population: 2 Groups: * 35 cases: Female Adolescents with AIS * 35 controls: Female subjects without scoliosis

Common Inclusion Criteria for the 2 groups :

  • Female subject aged 12 to < 18 years old
  • Affiliated to the French social security system
  • Having signed the inform consent form
  • Whose parents have given their consent

Additional Inclusion Criteria for the AIS group:

  • Subject with right thoracic AIS defined by the existence of a 3D spine deformation with a frontal deviation to right dorsal convexity with a Cobb angle of at least 20°, and a rotation of at least 20°, as evidenced by the presence of a vertebral gibbosity ≥ 5° at the Bunnel scoliometer.

If the scoliosis has more than one curvature, the right chest curvature should be the greatest high (highest frontal Cobb angle)

  • Subject with x-rays of total spine, face and profile under load, according to the EOS technique, dating from less than 3 months.

Common Exclusion Criteria for the 2 groups:

  • Instability to submit to the medical follow-up of the study for psychic, social or geographical reasons
  • At least 6 "cafe au lait" spots with a size ≥ 1.5 cm (may be suggestive of neurofibromatosis)
  • Ligament hyperlaxity confirmed by a Beighton score >4/9 (which may be suggestive of scoliosis secondary)
  • Contraindications of a cerebro-medullary MRI: claustrophobia, foreign bodies, and ferrometallic clips of the trunk or cephalic segment, cochlear implants, stimulators and implantable cardiac defibrillators, insulin pump
  • Inequality in length of the lower limbs ≥ 20 mm on clinical examination
  • Subject presenting neurological signs (signs of pyramidal irritation, sensory-motor deficit, clinical signs suggestive of cerebellar pathology ...)
  • Known vestibular pathology
  • Taking psychotropic drugs

Additional exclusion criterion for the AIS group:

  • Subject with secondary scoliosis : neurological, orthopedic, malformative...

Additional criteria for the control group:

  • Subject with a scoliosis angle ≥ 10° on a photogrammetric screening assessment (optical process, non-irradiating, which allows an Morphometric evaluation of the trunk in 3D, thanks to the analysis of the trunk reliefs)
  • Subject whose clinical examination shows a gibbosity measurable (>5°) with the scoliometer of Bunnel

Trial locations and contacts

2 sites in 1 country.

France2 sites
  • GHICL Hôpital Saint Philibert, service d'Imagerie Médicale

    Lomme, Nord, 59462

  • SSR Pédiatrique Marc Sautelet

    Villeneuve-d'Ascq, Nord (59), 59650

Other trials in France

About this study

Official title: Evaluation of Cerebrospinal Fluid Flow by MRI in Adolescent Idiopathic Scoliosis, From Its Signaling Through the Study of Trunk Graviception and Proprioception

Adolescent Idiopathic Scoliosis (AIS) is the most frequent spinal deformity in adolescence, but its etiology remains unknown. Recent publications suggest a link between ciliopathy and AIS. More specifically a modification of the cerebro-spinal fluid (CSF) flow by ciliary dysfunction could be at the origin of a scoliotic deformity.

This study aims to compare the CSF flow measured by magnetic resonance imaging (MRI) in an AIS group and a control group.

Being tested
Baseline Clinical Examination, Initial 3T MRI of the Brain and Spine, 6-month Follow-up Clinical Examination, 6-month Follow-up 3T MRI of the Brain and Spine
Keywords
cerebrospinal fluid flow, MRI, Graviception, Postural control

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Baseline Clinical ExaminationDiagnostic test

    Evaluations of Postural control; Subjective postural vertical; Subjective visual vertical; Verticality perception

  • Initial 3T MRI of the Brain and SpineRadiation

    Non-injected CSF flow MRI

  • 6-month Follow-up Clinical ExaminationDiagnostic test

    Evaluations of Postural control; Subjective postural vertical; Subjective visual vertical; Verticality perception

  • 6-month Follow-up 3T MRI of the Brain and SpineRadiation

    Non-injected CSF flow MRI

Study groups in NCT04760808
Study groupRoleWhat they receive
AIS groupNot described
Receives: Diagnostic Test: Baseline Clinical Examination; Radiation: Initial 3T MRI of the Brain and Spine; Diagnostic Test: 6-month Follow-up Clinical Examination; Radiation: 6-month Follow-up 3T MRI of the Brain and Spine
Control GroupNot described
Receives: Diagnostic Test: Baseline Clinical Examination; Radiation: Initial 3T MRI of the Brain and Spine

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. CSF flow (cm/s) at the 7th thoracic vertebra (T7)

    The flow will be measured by MRI

    Measured: 6 months

Secondary outcomes (13)
  1. CSF flow (cm/s) at the cervico-occipital junction

    The flow will be measured by MRI

    Measured: 6 months

  2. CSF flow (cm/s) at the cerebral aqueduct

    The flow will be measured by MRI

    Measured: 6 months

  3. Prevalence of spinal cord abnormalities

    Measured by MRI

    Measured: 6 months

  4. Correlation between the Body Mass Index and the CSF flow (cm/s) at the 7th thoracic vertebra (T7)

    This association will be studied by a linear regression analysis

    Measured: 6 months

  5. Cobb frontal angle in degrees

    The measurement of radiographic parameters will be done with the EOS system. The EOS system is a new slot-scanning radiological device that allows simultaneous acquisition of frontal and lateral images. It is composed of two X-ray sources, shaped as fan beams through collimation slits.

    Measured: 6 month

  6. Distance between the vertical line passing through the middle of the sacrum and the vertical line passing through the spine of the 7th cervical vertebra.

    Measured: 6 month

  7. Angle of thoracic kyphosis T4-T12 in degrees

    The measurement of radiographic parameters will be done with the EOS system.

    Measured: 6 months

  8. Lumbar lordosis angle L1-L5 in degrees

    The measurement of radiographic parameters will be done with the EOS system.

    Measured: 6 months

  9. Lumbo-sacral angle L5-S1 in degrees

    The measurement of radiographic parameters will be done with the EOS system The measurement of radiographic parameters will be done with the EOS system.

    Measured: 6 months

  10. Pelvic incidence in degrees

    The measurement of radiographic parameters will be done with the EOS system

    Measured: 6 months

  11. Subjective Postural Vertical Measurement in degrees

    Measured: 6 months

  12. Subjective Visual Vertical Sight Measurement in degrees

    Measured: 6 months

  13. Proprioception Measurement in degrees

    Proprioception measurement obtained by trunk repositioning error test (Formetric system)

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Feb 2021
  2. Study start10 Feb 2021
  3. Primary completion4 May 2022
  4. Study completion4 May 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
72 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04760808
Sponsor's protocol ID
RC-P0093
Acronym
MEDULLOSCOL
Status last verified
Sep 2024
First submitted
16 Feb 2021
Last updated
19 Sep 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Adolescent Idiopathic Scoliosis, run by Lille Catholic University at 2 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Sep 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

CSF flow (cm/s) at the 7th thoracic vertebra (T7) (time frame: 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Sep 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in